These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28743024)

  • 1. A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single-Nucleotide Variant Detection.
    Lee C; Bae JS; Ryu GH; Kim NKD; Park D; Chung J; Kyung S; Joung JG; Shin HT; Shin SH; Kim Y; Kim BS; Lee H; Kim KM; Kim JS; Park WY; Son DS
    J Mol Diagn; 2017 Sep; 19(5):651-658. PubMed ID: 28743024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.
    Misyura M; Zhang T; Sukhai MA; Thomas M; Garg S; Kamel-Reid S; Stockley TL
    J Mol Diagn; 2016 Nov; 18(6):842-850. PubMed ID: 27770852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.
    Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX
    Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology.
    Lucarelli M; Porcaro L; Biffignandi A; Costantino L; Giannone V; Alberti L; Bruno SM; Corbetta C; Torresani E; Colombo C; Seia M
    J Mol Diagn; 2017 Sep; 19(5):788-800. PubMed ID: 28736296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing.
    Zeng Q; Leach NT; Zhou Z; Zhu H; Smith JA; Rosenblum LS; Kenyon A; Heim RA; Eisenberg M; Letovsky S; Okamoto PM
    Sci Rep; 2020 Sep; 10(1):15060. PubMed ID: 32929119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
    Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
    BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays.
    Sims DJ; Harrington RD; Polley EC; Forbes TD; Mehaffey MG; McGregor PM; Camalier CE; Harper KN; Bouk CH; Das B; Conley BA; Doroshow JH; Williams PM; Lih CJ
    J Mol Diagn; 2016 May; 18(3):336-349. PubMed ID: 27105923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing.
    Duncavage EJ; Abel HJ; Merker JD; Bodner JB; Zhao Q; Voelkerding KV; Pfeifer JD
    Arch Pathol Lab Med; 2016 Oct; 140(10):1085-91. PubMed ID: 27388684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control metrics improve repeatability and reproducibility of single-nucleotide variants derived from whole-genome sequencing.
    Zhang W; Soika V; Meehan J; Su Z; Ge W; Ng HW; Perkins R; Simonyan V; Tong W; Hong H
    Pharmacogenomics J; 2015 Aug; 15(4):298-309. PubMed ID: 25384574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments.
    Qi Y; Liu X; Liu CG; Wang B; Hess KR; Symmans WF; Shi W; Pusztai L
    PLoS One; 2015; 10(7):e0119230. PubMed ID: 26136146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule Tags.
    Eijkelenboom A; Kamping EJ; Kastner-van Raaij AW; Hendriks-Cornelissen SJ; Neveling K; Kuiper RP; Hoischen A; Nelen MR; Ligtenberg MJ; Tops BB
    J Mol Diagn; 2016 Nov; 18(6):851-863. PubMed ID: 27637301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and analytical validation of an 82-gene comprehensive genome-profiling panel for identifying and interpreting variants responsible for inherited retinal dystrophies.
    Chan J; Holdstock J; Shovelton J; Reid J; Speight G; Molha D; Pullabhatla V; Carpenter S; Uddin E; Washio T; Sato H; Izumi Y; Watanabe R; Niiro H; Fukushima Y; Ashida N; Hirose T; Maeda A
    PLoS One; 2024; 19(6):e0305422. PubMed ID: 38870140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations.
    Concolino P; Costella A; Minucci A; Scaglione GL; Santonocito C; Salutari V; Scambia G; Zuppi C; Capoluongo E
    Clin Chim Acta; 2014 Nov; 437():72-7. PubMed ID: 25007954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution.
    Stead LF; Sutton KM; Taylor GR; Quirke P; Rabbitts P
    Hum Mutat; 2013 Oct; 34(10):1432-8. PubMed ID: 23766071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.
    Robyns T; Kuiperi C; Breckpot J; Devriendt K; Souche E; Van Cleemput J; Willems R; Nuyens D; Matthijs G; Corveleyn A
    Eur J Hum Genet; 2017 Dec; 25(12):1313-1323. PubMed ID: 29255176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.